Janux Therapeutics JANX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $52.33M-87.8% | $430.61M+2,142% | $19.21M-62.7% | $51.43M+44.5% | ||
| $914.23M+53.8% | $594.57M+83.0% | $324.82M+17.9% | $275.59M-18.8% | ||
| $816K0.0% | $816K0.0% | $816K0.0% | $816K0.0% | ||
| —— | —— | $0-100% | $500K+107% | ||
| $37.15M+18.6% | $31.31M+52.9% | $20.48M+15.6% | $17.72M+186% | ||
| $975.89M-5.6% | $1.03B+196% | $349.24M+5.1% | $332.44M-11.8% | ||
| $3.85M-20.8% | $4.86M-30.5% | $7M-1.2% | $7.09M+402% | ||
| $18.4M-4.6% | $19.29M-7.4% | $20.84M-6.5% | $22.28M+11,943% | ||
| $2.61M-9.6% | $2.88M+14.9% | $2.51M+80.5% | $1.39M+255% | ||
| $1B-5.6% | $1.06B+179% | $380.41M+4.5% | $364.01M-4.2% | ||
| $14.19M+42.0% | $10M+12.4% | $8.89M-10.8% | $9.96M+47.1% | ||
| $17.63M+50.9% | $11.68M+58.2% | $7.39M-9.7% | $8.18M+116% | ||
| $0— | $0-100% | $1.71M-68.5% | $5.41M+4.7% | ||
| $2.39M+36.8% | $1.75M+15.3% | $1.52M+98.8% | $763K+293% | ||
| $0— | —— | $0-100% | $2.22M+217% | ||
| $25M+43.2% | $17.46M+34.0% | $13.03M-21.0% | $16.51M+29.0% | ||
| $19.75M-7.2% | $21.28M-7.6% | $23.03M-6.2% | $24.54M— | ||
| $22.14M-3.8% | $23.03M-6.2% | $24.54M-3.0% | $25.31M+12,944% | ||
| $44.74M+15.5% | $38.74M+7.4% | $36.06M-16.7% | $43.27M+221% | ||
| $0— | —— | —— | —— | ||
| $60K+1.7% | $59K+28.3% | $46K+9.5% | $42K+2.4% | ||
| $1.3B+3.6% | $1.26B+146% | $512.4M+18.4% | $432.7M+4.5% | ||
| -$351.38M-47.8% | -$237.76M-40.9% | -$168.76M-52.8% | -$110.47M-133% | ||
| $4.32M+99.5% | $2.16M+225% | $665K+143% | -$1.54M-469% | ||
| $956.82M-6.4% | $1.02B+197% | $344.35M+7.4% | $320.74M-12.4% | ||
| $1B-5.6% | $1.06B+179% | $380.41M+4.5% | $364.01M-4.2% | ||
| $2.61M-9.6% | $2.88M+14.9% | $2.51M+80.5% | $1.39M+255% | ||
| $18.4M-4.6% | $19.29M-7.4% | $20.84M-6.5% | $22.28M+11,943% | ||
| $18.4M-4.6% | $19.29M-7.4% | $20.84M-6.5% | $22.28M+11,943% | ||
| $2.61M-9.6% | $2.88M+14.9% | $2.51M+80.5% | $1.39M+255% | ||
| $914.23M+53.8% | $594.57M+83.0% | $324.82M+17.9% | $275.59M-18.8% | ||
| $18.4M-4.6% | $19.29M-7.4% | $20.84M-6.5% | $22.28M+11,943% | ||
| $2.61M-9.6% | $2.88M+14.9% | $2.51M+80.5% | $1.39M+255% | ||
| $0— | —— | $0-100% | $2.22M+217% | ||
| $17.63M+50.9% | $11.68M+58.2% | $7.39M-9.7% | $8.18M+116% | ||
| $17.63M+50.9% | $11.68M+58.2% | $7.39M-9.7% | $8.18M+116% | ||
| $0— | —— | $0-100% | $2.22M+217% | ||
| $0— | —— | $0-100% | $2.22M+217% | ||
| $22.14M-3.8% | $23.03M-6.2% | $24.54M-3.0% | $25.31M+12,944% | ||
| $1.3B+3.6% | $1.26B+146% | $512.4M+18.4% | $432.7M+4.5% | ||
| $60K+1.7% | $59K+28.3% | $46K+9.5% | $42K+2.4% | ||
| $0— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Janux Therapeutics's total assets?
- Janux Therapeutics (JANX) holds $1.0B in total assets, down 2.1% year over year.
- How much debt does Janux Therapeutics have?
- Janux Therapeutics carries $21.6M in total debt against $941.5M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Janux Therapeutics have?
- Janux Therapeutics holds $51.8M in cash and equivalents.
- Can Janux Therapeutics cover its short-term obligations?
- Its current ratio is 17.01 — current assets exceed current liabilities.
- Where does Janux Therapeutics's balance sheet data come from?
- Every line is extracted from Janux Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
